Wall Street looks higher despite falling Netflix shares

0

IN NUMBERS

U.S. stock futures rose on Wednesday despite Netflix (NFLX) falling 27% in pre-market, the morning after reporting a quarterly loss in subscribers for the first time in more than a decade. Netflix’s carnage has hit other video streaming stocks, with Disney, Roku, Warner Bros. Discovery and Paramount all set for significantly lower openings. (CNBC)

Dow stock IBM (IBM) rose 2.5% pre-market after reporting on Tuesday night that quarterly earnings and revenue beat estimates. In regular trading on Tuesday, the Dow Jones, S&P 500 and Nasdaq all snapped two-session losing streaks even as the 10-year Treasury yield hit an over-three-year high of 2.94 %. The benchmark yield fell from that level on Wednesday. (CNBC)

Demand for mortgages continued to slump as home loan rates hit their highest level since 2010. Total application volume fell 5% week-over-week, and it fell nearly 50% from the previous year’s levels. Refinance demand fell another 8% from the previous week, and it was down 68% year-over-year. Purchase requests fell 3% on the week, and were 14% lower than a year ago. (CNBC)

IN THE NEWS TODAY

STOCKS TO MONITOR

Baker Hughes (BKR) fell 5 cents from estimates with adjusted quarterly earnings of 15 cents per share, and revenue also missed forecasts. The oil services company said its results reflected a volatile operating environment. The stock fell 2% pre-market.

Lululemon (LULU) added 2.2% in the pre-market after the apparel maker announced a five-year plan to double revenue. The plan aims to quadruple international sales and double revenue from its menswear and digital businesses.

ASML’s (ASML) latest quarter beat analysts’ forecasts on the high and low, with the Amsterdam-based semiconductor equipment maker reporting strong demand from chipmakers trying to increase production. ASML shares jumped 5.4% premarket.

Teva Pharmaceutical (TEVA) fell 4.8% in premarket trading after the FDA issued a rejection letter in response to a new drug application for a treatment of schizophrenia. Teva said it is exploring possible next steps and will work with the FDA to address the agency’s concerns.

Omnicom (OMC) posted better-than-expected earnings and revenue for its latest quarter, despite what the ad agency operator called “particularly challenging global events”. Omnicom took a $113.4 million charge related to its investment in Russian companies. The shares added 3.7% in premarket action.

WATER COOLER

Share.

Comments are closed.